Anthony S. Fauci, the country’s leading infectious-disease expert, said Monday that he’s “cautiously optimistic” about a potential coronavirus vaccine now entering the last phase of testing through a joint partnership between the NIH and Moderna.

The two-dose vaccine from Moderna is designed to prompt the immune system to produce antibodies against a portion of the coronavirus “spike” protein, which the virus uses to bind to and enter human cells. The vaccine uses messenger RNA (mRNA), a molecule critical for the virus to produce protein.

Dr. Scott Gottlieb, member of the boards of Pfizer, Tempus and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss the latest in the fight against Covid-19.


finviz dynamic chart for  mrna finviz dynamic chart for  spy

Don’t miss these catalysts!

We don’t spam! Read our privacy policy for more info.